Efficacy of Prophylactic and Therapeutic Administration of Antitoxin for Inhalation Botulism

  • David R. Franz
  • Louise M. Pitt
  • Michael A. Clayton
  • Martha A. Hanes
  • Kenneth J. Rose

Abstract

Botulism is caused by intoxication with one or more of the seven neurotoxins produced by Clostridium botulinum. Food poisoning is the most common cause of botulism. Accidental inhalation exposure, however, has been reported in the laboratory,4 and inhalation is the likely route of exposure after the toxin’s use as a terrorist weapon or warfare agent. Toxoids are available for immunization, but there are presently no known drugs that can be used to prevent or treat botulinum intoxication. A pentavalent human, hyperimmune globulin product6 and a heptavalent, equine F(ab’)2 (despeciated) antitoxin (unpublished data, G.E. Lewis, Jr. and R.M. Condie) were evaluated in a preliminary study as prophylaxis or therapy for inhalation botulism (serotype A) in rhesus monkeys.

Keywords

Botulinum Toxin Minute Volume Clostridium Botulinum Mouth Breathing Aerosol Challenge 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cardella MS. Botulinum toxoids. In: Lewis KH, Cassel K, eds. Botulism. Cincinnati, OH: Department of Health Education and Welfare, Public Health Service, 1964.Google Scholar
  2. 2.
    Ellis RJ. Immunobiologic agents and drugs available from the Centers for Disease Control: descriptions, recommendations, adverse reactions, and serologic response, Atlanta, GA: Centers for Disease Control, 1982.Google Scholar
  3. 3.
    Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Physiol 1947; 150: 70.PubMedGoogle Scholar
  4. 4.
    Holzer E. Botulism caused by inhalation. Med Klin 1962; 41: 1735.Google Scholar
  5. 5.
    Lewis GE Jr., Metzger JF. Studies on the prophylaxis and treatment of botulism. In: Eaker D, Wadstrom T, eds. Natural Toxins. Oxford: Pergamon Press, 1980.Google Scholar
  6. 6.
    Metzger JF, Lewis GE Jr. Human-derived immune globulins for the treatment of botulism. In: Reviews of Infectious Diseases. Chicago, IL: The University of Chicago, 1979Google Scholar
  7. 7.
    Oberst FW, Crook JW, Cresthull P, House MJ. Evaluation of botulinum antitoxin, supportive therapy, and artificial respiration in monkeys with experimental botulism. Clin Pharm Ther 1967; 9: 209.Google Scholar
  8. 8.
    Simpson LL. Peripheral Actions of Botulinum Toxins. In: Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. New York, NY: Academic Press, Inc., 1989.Google Scholar
  9. 9.
    Thompson WR, Weil CS. On the construction of tables for moving-average interpolation. Biometrics 1952; 8: 51.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • David R. Franz
    • 1
  • Louise M. Pitt
    • 1
  • Michael A. Clayton
    • 1
  • Martha A. Hanes
    • 2
  • Kenneth J. Rose
    • 3
  1. 1.Toxinology Divisions U.S. Army Medical Research Institute of Infectious DiseasesFort DetrickFrederickUSA
  2. 2.Pathology Divisions U.S. Army Medical Research Institute of Infectious DiseasesFort DetrickFrederickUSA
  3. 3.Veterinary Medicine Divisions U.S. Army Medical Research Institute of Infectious DiseasesFort DetrickFrederickUSA

Personalised recommendations